NHS England makes landmark decision on puberty blockers

Gender Clinic News’ Bernard Lane discusses NHS England’s landmark decision to stop prescribing puberty blockers to children with gender dysphoria. Mr Lane said an independent expert review found the evidence for puberty blockers was “very weak” and “uncertain”. “We don’t know if they’re safe – we don’t know what effect they have,” he told Sky News host Peta Credlin. “Also … the spike in patient numbers and the change in the patient profile. “So, the National Health Service England has decided that the puberty blockers should no longer be offered as a routine treatment to young people who are distressed about their gender.”